Related references
Note: Only part of the references are listed.MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
Margaret Yeh et al.
SCIENTIFIC REPORTS (2021)
MS-275 potentiates the effect of YM-155 in lung adenocarcinoma via survivin downregulation induced by miR-138 and miR-195
Bai-Ling Luo et al.
THORACIC CANCER (2019)
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis
Jun-Hai Tang et al.
CANCER COMMUNICATIONS (2019)
Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
Fengmei Pi et al.
NATURE NANOTECHNOLOGY (2018)
alpha-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA-138 expression
Jianbo Wu et al.
ONCOLOGY REPORTS (2018)
MicroRNA-Based Drugs for Brain Tumors
Shubaash Anthiya et al.
TRENDS IN CANCER (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Tae Jin Lee et al.
MOLECULAR THERAPY (2017)
MiR-138: A promising therapeutic target for cancer
Huan-Huan Sha et al.
TUMOR BIOLOGY (2017)
Strategies of temozolomide in future glioblastoma treatment
Chooi Yeng Lee
ONCOTARGETS AND THERAPY (2017)
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei et al.
NEURO-ONCOLOGY (2016)
miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells
Rong Yang et al.
MOLECULAR CANCER (2016)
Survivin and gliomas: A literature review
Rosilin Kotakkathu Varughese et al.
ONCOLOGY LETTERS (2016)
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
Nina Stojcheva et al.
ONCOTARGET (2016)
Survivin: A molecular biomarker in cancer
Praveen Kumar Jaiswal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
Tae Jin Lee et al.
ONCOTARGET (2015)
被撤回的出版物: Recurrent Glioblastoma: Where we stand(Retracted article. See vol. 6, pg. 153, 2017)
Sanjoy Roy et al.
SOUTH ASIAN JOURNAL OF CANCER (2015)
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Sadhak Sengupta et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics
Dan Shu et al.
NATURE NANOTECHNOLOGY (2011)
Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
Chang-Hyun Kim et al.
IMMUNOLOGY (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Targeted therapy for brain tumours
MS Lesniak et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
